Fig. 2From: SNHG29 regulates miR-223-3p/CTNND1 axis to promote glioblastoma progression via Wnt/β-catenin signaling pathwaySNHG29 directly interacted with miR-223-3p in glioblastoma. a Nuclear-cytoplasmic fractionation was conducted to locate SNHG29. b The predicted miRNAs were shown. c The predicted miRNAs expression in glioblastoma tissues was measured by RT-qPCR. d–f The expression of SNHG29 or miR-223-3p was monitored by RT-qPCR. g The correlation between SNHG29 and miR-223-3p was depicted. h The binding site of miR-223-3p on SNHG29 was shown. i, j The binding capacity between SNHG29 and miR-223-3p was testified by RIP and luciferase reporter assays. *P < 0.05, **P < 0.01Back to article page